VIVIAN BRACERO: Open Payments
NPI 1265083430 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 32 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $932 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $141 |
| Novo Nordisk Inc | 3 | $78 |
| ABBVIE INC. | 4 | $74 |
| Lilly USA, LLC | 3 | $70 |
| Amgen Inc. | 3 | $62 |
| Exact Sciences Corporation | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
Products named: VTAMA, MOUNJARO, OTEZLA, Wegovy, TREMFYA, Kerendia, COSENTYX, RINVOQ.
Industry payments across VA — which companies pay providers there.
